Industrial Biotechnology Corp.; Rated 'Speculative Buy,' Target Price $2.20 by Beacon Equity Research

Industrial Biotechnology Corp.; Rated 'Speculative Buy,' Target Price $2.20 by Beacon Equity Research

DALLAS - Industrial Biotechnology Corp. (OTC.PK: IBOT) has been rated Speculative Buy with a price target of $2.20 by Beacon Analyst, Victor Sula, Ph.D.

The full report is available at http://www.beaconequity.com/adpages/IBOT.

Anyone interested in receiving alerts regarding IBOT research should e-mail members@beaconequity.com with “IBOT” in the subject line.

In the report, the analyst writes, “… based on our understanding of IBOT’s business model and our discussions with management, we believe the Company has a good chance of becoming a rising star in the U.S. biofuel market … IBOT has formed a strategic alliance with Cosan SA, to provide ethanol for the Company's Renewable Fuels of America Inc. and Renewable Chemicals Corp. subsidiaries … and plans to commence shipments of sugar cane ethanol into the U.S. market in late 2008 or early 2009.”

Other companies in the alternative energy sector include: Pacific Ethanol Inc. (Nasdaq: PEIX ), Verasun Energy Corp. (NYSE: VSE), Aventine Renewable Energy (NYSE: AVR) and Archer-Daniels-Midland Co. (NYSE: ADM).

Beacon Equity Research Disclosure

The analysts contributing to this report do not hold any shares of IBOT. Additionally the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research (“Beacon”) certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report.

BER and its affiliates have been compensated twenty three thousand dollars a month from Rovert Consulting for enrollment of IBOT in its research program and other services. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.

Industrial Biotechnology Corporation is a featured Company on Investorideas.com Green portals, BiotechIndustryStocks.com.

For showcase click here: http://www.renewableenergystocks.com/CO/IBOT/Default.asp
Disclaimer : /About/Disclaimer.asp
Pink sheet disclaimer : http://www.pinksheets.com/pink/otcguide/investors_protection.jsp

Contact:
BeaconEquity.com
Jeff Bishop, 469-252-3505
press@beaconequity.com
www.BeaconEquity.com
or
Industrial Biotechnology Corp.
Craig McClure, 941-925-2500 ext. 3084

Source: Industrial Biotechnology Corp.